BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18420166)

  • 1. Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins.
    Enriquez JR; Pratap P; Zbilut JP; Calvin JE; Volgman AS
    Gend Med; 2008 Mar; 5(1):53-61. PubMed ID: 18420166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home.
    Joseph J; Koka M; Aronow WS
    J Am Med Dir Assoc; 2008 Feb; 9(2):124-7. PubMed ID: 18261706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
    Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease.
    Ndrepepa G; Braun S; Schömig A; Kastrati A
    Clin Res Cardiol; 2011 Apr; 100(4):327-33. PubMed ID: 21053005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receipt of cardiac medications upon discharge among men and women with acute coronary syndrome and nonobstructive coronary artery disease.
    Ramanath VS; Armstrong DF; Grzybowski M; Rahnama-Mohagdam S; Tamhane UU; Gordon K; Froehlich JB; Eagle KA; Jackson EA
    Clin Cardiol; 2010 Jan; 33(1):36-41. PubMed ID: 20063300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underutilization of aspirin, beta blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs and overutilization of calcium channel blockers in older persons with coronary artery disease in an academic nursing home.
    Ghosh S; Ziesmer V; Aronow WS
    J Gerontol A Biol Sci Med Sci; 2002 Jun; 57(6):M398-400. PubMed ID: 12023270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of an anesthesia information system to identify and trend gender disparities in outpatient medical management of patients with coronary artery disease.
    Vigoda MM; Rodríguez LI; Wu E; Perry K; Duncan R; Birnbach DJ; Lubarsky DA
    Anesth Analg; 2008 Jul; 107(1):185-92. PubMed ID: 18635487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex Differences in Cardiac Medication Use Post-Catheterization in Patients Undergoing Coronary Angiography for Stable Angina with Nonobstructive Coronary Artery Disease.
    Galway S; Adatia F; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Sep; 26(9):976-983. PubMed ID: 28384013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis.
    Hippisley-Cox J; Coupland C
    BMJ; 2005 May; 330(7499):1059-63. PubMed ID: 15879390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
    Ezekowitz J; McAlister FA; Humphries KH; Norris CM; Tonelli M; Ghali WA; Knudtson ML;
    J Am Coll Cardiol; 2004 Oct; 44(8):1587-92. PubMed ID: 15489090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.
    Granmyr J; Ball P; Curran S; Wang L
    Aust J Rural Health; 2007 Aug; 15(4):241-6. PubMed ID: 17617087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin and beta-blocker therapy and the initial presentation of coronary heart disease.
    Go AS; Iribarren C; Chandra M; Lathon PV; Fortmann SP; Quertermous T; Hlatky MA;
    Ann Intern Med; 2006 Feb; 144(4):229-38. PubMed ID: 16490908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease.
    Ho PM; Magid DJ; Shetterly SM; Olson KL; Maddox TM; Peterson PN; Masoudi FA; Rumsfeld JS
    Am Heart J; 2008 Apr; 155(4):772-9. PubMed ID: 18371492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.
    Sharma KK; Gupta R; Agrawal A; Roy S; Kasliwal A; Bana A; Tongia RK; Deedwania PC
    Vasc Health Risk Manag; 2009; 5():1007-14. PubMed ID: 19997570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Management of Coronary Artery Disease in Patients With Medicare Advantage vs Traditional Fee-for-Service Medicare Among Cardiology Practices.
    Figueroa JF; Blumenthal DM; Feyman Y; Frakt AB; Turchin A; Doros G; Gao Q; Song Y; Joynt Maddox KE
    JAMA Cardiol; 2019 Mar; 4(3):265-271. PubMed ID: 30785590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
    Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
    Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term adherence with cardiovascular drug regimens.
    Kulkarni SP; Alexander KP; Lytle B; Heiss G; Peterson ED
    Am Heart J; 2006 Jan; 151(1):185-91. PubMed ID: 16368315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between drug application and mortality rate in Chinese older coronary artery disease/chronic heart failure patients with and without low glomerular filtration rate.
    Fu S; Ping P; Ye P; Luo L
    BMC Pharmacol Toxicol; 2019 Jul; 20(1):44. PubMed ID: 31349878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cardiac medications for patients with obstructive coronary artery disease by coronary computed tomographic angiography: results from the multicenter CONFIRM registry.
    Schulman-Marcus J; Hartaigh BÓ; Giambrone AE; Gransar H; Valenti V; Berman DS; Budoff MJ; Achenbach S; Al-Mallah M; Andreini D; Cademartiri F; Callister TQ; Chang HJ; Chinnaiyan K; Chow BJ; Cury R; Delago A; Hadamitzky M; Hausleiter J; Feuchtner G; Kim YJ; Kaufmann PA; Leipsic J; Lin FY; Maffei E; Pontone G; Raff G; Shaw LJ; Villines TC; Dunning A; Min JK
    Atherosclerosis; 2015 Jan; 238(1):119-25. PubMed ID: 25479800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease.
    Adatia F; Galway S; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Nov; 26(11):1185-1192. PubMed ID: 28384014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.